In Vitro Activity of Ceftazidime–avibactam, Ceftolozane–tazobactam, and Other Comparable Agents Against Clinically Important Gram-Negative Bacilli: Results From the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
Infection and Drug Resistance - New Zealand
doi 10.2147/idr.s175679
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Informa UK Limited